FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

18769811000001106: Trobalt 400mg tablets (GlaxoSmithKline UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Jun 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
64170301000001118 Trobalt 400mg tablets (GlaxoSmithKline UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
64170401000001114 Trobalt 400mg tablets (GlaxoSmithKline UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Trobalt 400mg tablets (GlaxoSmithKline UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Trobalt 400mg tablets (GlaxoSmithKline UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Trobalt 400mg tablets (GlaxoSmithKline UK Ltd) Is a Retigabine 400mg tablets false Inferred relationship Existential restriction modifier
Trobalt 400mg tablets (GlaxoSmithKline UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Trobalt 400mg tablets (GlaxoSmithKline UK Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Trobalt 400mg tablets (GlaxoSmithKline UK Ltd) Has specific active ingredient Retigabine false Inferred relationship Existential restriction modifier
Trobalt 400mg tablets (GlaxoSmithKline UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Trobalt 400mg tablets (GlaxoSmithKline UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Trobalt 400mg tablets (GlaxoSmithKline UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Trobalt 400mg tablets (GlaxoSmithKline UK Ltd) Is a Trobalt true Inferred relationship Existential restriction modifier
Trobalt 400mg tablets (GlaxoSmithKline UK Ltd) Has specific active ingredient Retigabine true Inferred relationship Existential restriction modifier
Trobalt 400mg tablets (GlaxoSmithKline UK Ltd) Has active ingredient Retigabine false Inferred relationship Existential restriction modifier
Trobalt 400mg tablets (GlaxoSmithKline UK Ltd) Is a Product containing precisely retigabine 400 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Trobalt 400mg tablets (GlaxoSmithKline UK Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Trobalt 400mg tablets (GlaxoSmithKline UK Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Trobalt 400mg tablets (GlaxoSmithKline UK Ltd) 84 tablet 4 x 21 tablets Has AMP True Trobalt 400mg tablets (GlaxoSmithKline UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start